LifeWatch AG: Agreement signed to utilize Vital Connect Inc.'s HealthPatch(R) MD in its cardiac monitoring business
November 07 2014 - 4:09PM
Business Wire
Release of an ad hoc announcement pursuant to Art. 53 KR
LifeWatch AG signs agreement to utilize Vital Connect Inc.'s
HealthPatch(R) MD in its cardiac monitoring business
LifeWatch AG (SIX Swiss Exchange: LIFE), a leading provider of
medical solutions in remote cardiac monitoring, is pleased to
announce the signing of an agreement with Vital Connect Inc. to
utilize their HealthPatch MD as a 1-lead ECG device in its cardiac
monitoring business.
LifeWatch and Vital Connect are working together to integrate
the HealthPatch MD into LifeWatch's analytical mobile application
and reporting systems with a view to bringing an integrated
solution to market in the first half of 2015.
This move follows on the heels of the development of LifeWatch's
already announced Vital Signs Patch (VSP) which is also due for
release in the first half of 2015. Dr. Stephan Rietiker, CEO of
LifeWatch, noted: "I am very excited about the new partnership as
it comprises a breakthrough technology that will enable LifeWatch
to expand its cardiac monitoring device offerings for patients to
include the important patch technology area." Patch technology is
easy to use and should increase the effectiveness of cardiac
monitoring due to higher patient compliance.
Vital Connect Inc.'s HealthPatch MD biosensor for monitoring
patients received FDA clearance for home use in July 2014 and, as a
result of its weight and thickness (only 10 g and 6 mm (0.24"),
respectively), offers patients a much more comfortable and less
obtrusive monitoring solution in comparison to conventional
monitoring equipment.
About LifeWatch AG:
LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed
on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare
technology and solution company, specializing in advanced
telehealth systems and wireless remote patient monitoring services.
LifeWatch's services provide physicians with critical information
to determine appropriate treatment and thereby improve patient
outcomes. LifeWatch AG has operative subsidiaries in the United
States, in Switzerland and in Israel, and is the parent company of
LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch
Services, Inc. is a leading U.S.-based provider of cardiac
monitoring services and home sleep testing of Obstructive Sleep
Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a
leading developer and manufacturer of telemedicine products. For
additional information, please visit www.lifewatch.com.
Sign up for customized e-mail alerts and documentation requests
at http://www.irlifewatch.com/alert-service.aspx
About Vital Connect, Inc.: Vital Connect is a Silicon
Valley-based startup founded in 2011 with the goal to develop the
newest generation of technologies that help address some of the
most challenging healthcare issues in the world today. Vital
Connect's extensive expertise enables the company to create
wireless, wearable biosensors that are small, powerful, and capable
of capturing clinical-grade biometric measurements in a continuous,
configurable and non-obtrusive manner. Through various
partnerships, Vital Connect solutions will be available for use in
hospitals, research facilities, doctor's offices, care facilities
and homes. For more information, visit: www.vitalconnect.com.
This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results
of operations and financial position, the business strategy, and
plans and objectives for future operations, are forward-looking
statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar
expressions are intended to identify forward-looking statements.
LifeWatch AG has based these forward-looking statements largely on
current expectations and projections about future events and
financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and
long-term business operations and objectives, and financial needs.
These forward-looking statements are subject to a number of risks,
uncertainties and assumptions. In light of these risks,
uncertainties and assumptions, the forward-looking events and
circumstances described may not occur and actual results could
differ materially and adversely from those anticipated or implied
in the forward-looking statements. All forward-looking statements
are based only on data available to LifeWatch AG at the time of the
issue of this press release. LifeWatch AG does not undertake any
obligation to update any forward-looking statements contained in
this press release as a result of new information, future events or
otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF
LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED
STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY
SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED
STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS
SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN
THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER
OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF
SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF
A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS
SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION
ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS
OF THE ISSUER.
Language: English Company: LifeWatch AG Rundbuckstrasse 6 8212
Neuhausen am Rheinfall Switzerland Phone: +41 52 632 00 50 Fax: +41
52 632 00 51 E-mail: Internet: www.lifewatch.com ISIN: CH0012815459
Valor: 811189 Listed: Freiverkehr in Berlin, Stuttgart; Frankfurt
in Open Market ; SIX
For further questions:LifeWatch AG c/o Dynamics GroupPhilippe
Blangey / Doris Rudischhauser, +41 43 268 32
35investor-relations@lifewatch.com
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Aug 2024 to Sep 2024
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Sep 2023 to Sep 2024